Related Experiment Videos
Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline
C W Song1, T Hasegawa, H C Kwon
1University of Minnesota Medical School, Department of Therapeutic Radiology-Radiation Oncology, Minneapolis 55455.
Radiation Research
|May 1, 1992
Summary
Pentoxifylline (PTX) increases oxygen levels in tumors, enhancing the effectiveness of radiation therapy. This study shows PTX
Area of Science:
- Oncology
- Pharmacology
- Radiation Biology
Background:
- Pentoxifylline (PTX) is a medication used for vascular disorders.
- Tumor hypoxia (low oxygen) is a known factor limiting radiation therapy efficacy.
Purpose of the Study:
- To investigate the effect of pentoxifylline (PTX) on tumor oxygen levels (pO2).
- To evaluate the impact of PTX on the radioresponse of tumors.
Main Methods:
- Administered PTX intraperitoneally to mice bearing SCK or FSa-II tumors.
- Measured tumor pO2 at various time points after PTX injection.
- Assessed tumor growth delay following X-irradiation after PTX administration.
Main Results:
- PTX administration led to a transient increase in tumor pO2.
- Higher PTX doses prolonged the elevation of tumor oxygen levels.
- PTX combined with X-irradiation resulted in greater tumor growth delay compared to X-irradiation alone.
Conclusions:
- Pentoxifylline (PTX) effectively increases tumor oxygenation.
- PTX shows potential as an adjunct to radiation therapy for improving tumor radioresponse.